NASDAQ:OCUL

Insiders Updates

0 analysts rank OCUL stock as an Overweight

Daniel Torres

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ocular Therapeutix ...

Analysts Viewpoint

Insider Selling: Saroj Namrata, Ocular Therapeutix Inc [OCUL] Chief Business Officer divested 25,865 shares

Roman Campbell

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Analysts Viewpoint

Rise in OCUL’s short interest indicates Bearish sentiment

Daniel Torres

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.